Cutera Total Long Term Liabilities 2010-2024 | CUTR
Cutera total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
Cutera Annual Total Long Term Liabilities (Millions of US $) |
2023 |
$430 |
2022 |
$430 |
2021 |
$150 |
2020 |
$21 |
2019 |
$9 |
2018 |
$4 |
2017 |
$3 |
2016 |
$2 |
2015 |
$3 |
2014 |
$5 |
2013 |
$6 |
2012 |
$4 |
2011 |
$3 |
2010 |
$3 |
2009 |
$4 |
Cutera Quarterly Total Long Term Liabilities (Millions of US $) |
2024-09-30 |
$432 |
2024-06-30 |
$432 |
2024-03-31 |
$432 |
2023-12-31 |
$430 |
2023-09-30 |
$430 |
2023-06-30 |
$430 |
2023-03-31 |
$430 |
2022-12-31 |
$430 |
2022-09-30 |
$314 |
2022-06-30 |
$315 |
2022-03-31 |
$149 |
2021-12-31 |
$150 |
2021-09-30 |
$150 |
2021-06-30 |
$151 |
2021-03-31 |
$152 |
2020-12-31 |
$21 |
2020-09-30 |
$26 |
2020-06-30 |
$16 |
2020-03-31 |
$8 |
2019-12-31 |
$9 |
2019-09-30 |
$12 |
2019-06-30 |
$12 |
2019-03-31 |
$11 |
2018-12-31 |
$4 |
2018-09-30 |
$3 |
2018-06-30 |
$4 |
2018-03-31 |
$3 |
2017-12-31 |
$3 |
2017-09-30 |
$3 |
2017-06-30 |
$3 |
2017-03-31 |
$3 |
2016-12-31 |
$2 |
2016-09-30 |
$2 |
2016-06-30 |
$2 |
2016-03-31 |
$3 |
2015-12-31 |
$3 |
2015-09-30 |
$3 |
2015-06-30 |
$4 |
2015-03-31 |
$5 |
2014-12-31 |
$5 |
2014-09-30 |
$6 |
2014-06-30 |
$6 |
2014-03-31 |
$6 |
2013-12-31 |
$6 |
2013-09-30 |
$5 |
2013-06-30 |
$5 |
2013-03-31 |
$4 |
2012-12-31 |
$4 |
2012-09-30 |
$3 |
2012-06-30 |
$3 |
2012-03-31 |
$3 |
2011-12-31 |
$3 |
2011-09-30 |
$3 |
2011-06-30 |
$3 |
2011-03-31 |
$3 |
2010-12-31 |
$3 |
2010-09-30 |
$3 |
2010-06-30 |
$3 |
2010-03-31 |
$4 |
2009-12-31 |
$4 |
2009-09-30 |
$5 |
2009-06-30 |
$6 |
2009-03-31 |
$7 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Laser Systems and Components |
$0.006B |
$0.212B |
Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system.
|